## Abstract Transmitted drug resistance (TDR) is a concern because it may reduce the efficacy of antiretroviral treatment. Plasma samples of 119 HIV‐1‐infected patients who were newly diagnosed at the Infectology Center of Latvia in 2005 and 2006 were analyzed by an in‐house genotypic resistance as
HIV-1- prevalence among drug deaths in major cities of central and northern Europe
✍ Scribed by K. Püschel; U. Lockemann; V. Schneider; H.-F. Brettel; R. Penning; J. Rajs; A. Fugelstad; B. Kringsholm; D. Risser; B. Vonlanthen
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 405 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0379-0738
No coin nor oath required. For personal study only.
✦ Synopsis
Since 1985, a number of Institutes of Forensic Medicine in Germany have cooperated in a multicenter study, to provide a constant monitoring of HIV-1-prevalence among drug related deaths. In 1990/91, the Institutes in Copenhagen, Stockholm, Vienna and Zürich also participated in this study. HIV-1-prevalence is decreasing in the German cities, whereas the epidemiological development is not uniform in the other major cities. Regional differences are obvious. In 1991, the prevalence rates were as follows: Berlin 15% (n = 220), Hamburg 4% (n = 179), Frankfurt 17% (n = 167), Munich 9% (n = 136), Stockholm 10% (n = 79), Copenhagen 14% (n = 130), Vienna 20% (n = 56), and Zürich 23% (n = 84).
📜 SIMILAR VOLUMES
## Abstract Few reports have described the molecular characteristics of the AIDS epidemic within the interior regions of Brazil, a country of continental dimensions. To help fill this gap, the prevalence of transmitted antiretroviral drug resistance and human immunodeficiency virus type 1 (HIV‐1) d